Arterium
Nataliia Zaiets is an experienced financial reporting and planning manager currently working at Arterium since May 2019, specializing in the preparation of consolidated financial statements, budgets, and forecasts, along with optimizing management accounting reporting. Prior to this role, Nataliia served as a Group Reporting Manager at Нова Пошта from March 2017 to April 2019, where responsibilities included management reporting and external audit support. From November 2012 to March 2017, Nataliia was a Senior Auditor at Baker Tilly (Ukraine), managing audit projects across various sectors and ensuring compliance with IFRS and Ukrainian GAAP. Academic achievements include a Master’s degree in Financial Controlling and a Bachelor’s degree in Finance from Kyiv National Economic University.
Arterium
1 followers
The Arterium Corporation operates in the industry which takes care of the most important values – human health and life. Every day nearly two thousand of our employees make their individual contribution to the achievement of this humane goal. We strive to ensure that every patient who uses our medicines, every doctor who is determined to overcome disease, every business partner – feels our care, responsibility, and confidence we put into high quality and effectiveness of our products. That is why the Arterium Corporation has a corporate philosophy and attitude of cooperation towards patients, doctors and business partners which is firmly based on the concept “Closer to people”. We are certain that in order to create and develop high quality and effective medications it is necessary to possess the requisite knowledge, technology, and business acumen as well as to cultivate among our employees a selfless and heartfelt attitude towards their work allied with a deep understanding of the significance of our corporate mission and values. That is why guided by our “Closer to people” idea, the Arterium Corporation is one of the leading pharmaceutical companies in Ukraine and is steadily expanding its presence on CIS markets.